Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria. 2023

Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
Department of Oncological and Vascular Intervention, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.

BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) is the standard second-line treatment option for individuals with complications of decompensated cirrhosis, such as variceal bleeding and refractory ascites. OBJECTIVE To investigate whether recompensation existed in TIPS-treated patients with decompensated cirrhosis according to Baveno VII criteria. METHODS This retrospective analysis was performed on 64 patients who received TIPS for variceal bleeding or refractory ascites. The definition of recompensation referred to Baveno VII criteria and previous study. Clinical events, laboratory tests, and radiological examinations were regularly conducted during a preset follow-up period. The recompensation ratio in this cohort was calculated. Beyond that, univariate and multivariate regression models were conducted to identify the predictors of recompensation. RESULTS Of the 64 patients with a 12-mo follow-up, 20 (31%) achieved recompensation. Age [odds ratio (OR): 1.124; 95% confidence interval (CI): 1.034-1.222] and post-TIPS portal pressure gradient < 12 mmHg (OR: 0.119; 95%CI: 0.024-0.584) were identified as independent predictors of recompensation in patients with decompensated cirrhosis after TIPS. CONCLUSIONS The present study demonstrated that nearly one-third of the TIPS-treated patients achieved recompensation within this cohort. According to our findings, recompensation is more likely to be achieved in younger patients. In addition, postoperative portal pressure gradient reduction below 12 mmHg contributes to the occurrence of recompensation.

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D004932 Esophageal and Gastric Varices Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL). Esophageal Varices,Gastric Varices,Esophageal Varix,Gastric Varix,Varices, Esophageal,Varices, Gastric,Varix, Esophageal,Varix, Gastric
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001201 Ascites Accumulation or retention of free fluid within the peritoneal cavity.
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D019168 Portasystemic Shunt, Transjugular Intrahepatic A type of surgical portasystemic shunt to reduce portal hypertension with associated complications of esophageal varices and ascites. It is performed percutaneously through the jugular vein and involves the creation of an intrahepatic shunt between the hepatic vein and portal vein. The channel is maintained by a metallic stent. The procedure can be performed in patients who have failed sclerotherapy and is an additional option to the surgical techniques of portocaval, mesocaval, and splenorenal shunts. It takes one to three hours to perform. (JAMA 1995;273(23):1824-30) Portosystemic Shunt, Transjugular Intrahepatic,TIPS,TIPSS,Shunt, Transjugular Intrahepatic Portasystemic,Shunt, Transjugular Intrahepatic Portosystemic,Transjugular Intrahepatic Portasystemic Shunt

Related Publications

Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
March 2024, World journal of gastroenterology,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
December 2022, Journal of hepatology,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
March 2021, United European gastroenterology journal,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
September 2021, Internal and emergency medicine,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
September 2023, JHEP reports : innovation in hepatology,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
December 2020, GE Portuguese journal of gastroenterology,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
August 2023, Journal of the Formosan Medical Association = Taiwan yi zhi,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
April 2023, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
November 2001, Journal of hepatology,
Long Gao, and Man-Biao Li, and Jin-Yu Li, and Yang Liu, and Chao Ren, and Dui-Ping Feng
April 2024, World journal of gastroenterology,
Copied contents to your clipboard!